China Shenwei Pharmaceutical Group

China Shenwei Pharmaceutical Group is a leading pharmaceutical company in China specializing in the research, development, manufacture, and marketing of modern Traditional Chinese Medicine (TCM). The company focuses on high-growth therapeutic areas including cardiovascular and cerebrovascular diseases, respiratory system ailments, and pediatric conditions. Its product portfolio features well-known brands such as Qingkailing Injection and Shenmai Injection, which are widely used in Chinese clinical settings. Shenwei operates large-scale manufacturing facilities that adhere to international GMP standards and is recognized for its modernization of TCM through advanced extraction and purification technologies. The group is listed on the Hong Kong Stock Exchange and maintains a dominant position in the TCM injection market.